Surmont VF - Search Results

1

Surmont VF, van Meerbeeck JP. Surmont VF, et al. Expert Rev Anticancer Ther. 2011 Oct;11(10):1481-90. doi: 10.1586/era.11.136. Expert Rev Anticancer Ther. 2011. PMID: 21999120 Review.

2

Unexpected response of a pulmonary blastoma on radiotherapy: a case report and review of the literature.

Surmont VF, van Klaveren RJ, Nowak PJ, Zondervan PE, Hoogsteden HC, van Meerbeeck JP. Surmont VF, et al. Lung Cancer. 2002 May;36(2):207-11. doi: 10.1016/s0169-5002(01)00465-2. Lung Cancer. 2002. PMID: 11955657 Review.

3

Lessons to learn from EORTC study 08981: a feasibility study of induction chemoradiotherapy followed by surgical resection for stage IIIB non-small cell lung cancer.

Surmont V, van Klaveren RJ, Goor C, Schramel F, Manegold C, Legrand C, Van Schil P, Van Meerbeeck JP. Surmont V, et al. Lung Cancer. 2007 Jan;55(1):95-9. doi: 10.1016/j.lungcan.2006.09.015. Epub 2006 Oct 27. Lung Cancer. 2007. PMID: 17069931

4

A phase II study of induction therapy with carboplatin and gemcitabine among patients with locally advanced non-small cell lung cancer.

Aerts JG, Surmont V, van Klaveren RJ, Tan KY, Senan S, van Wijhe G, Vernhout R, Verhoeven GT, Hoogsteden HC, van Meerbeeck JP. Aerts JG, et al. J Thorac Oncol. 2006 Jul;1(6):532-6. J Thorac Oncol. 2006. PMID: 17409913 Free article. Clinical Trial.

5

Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.

van Meerbeeck JP, Surmont VF. van Meerbeeck JP, et al. Among authors: surmont vf. Lung Cancer. 2009 Sep;65(3):257-67. doi: 10.1016/j.lungcan.2009.02.007. Epub 2009 Mar 13. Lung Cancer. 2009. PMID: 19285751 Review.

6

What is the role for surgery in patients with stage III non-small cell lung cancer?

Vandenbroucke E, De Ryck F, Surmont V, van Meerbeeck JP. Vandenbroucke E, et al. Curr Opin Pulm Med. 2009 Jul;15(4):295-302. doi: 10.1097/MCP.0b013e32832cbefc. Curr Opin Pulm Med. 2009. PMID: 19465855 Review.

7

Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studies.

Surmont V, Smit EF, de Jonge M, Aerts JG, Nackaerts K, Vernhout R, Gras J, Van Wijk A, Phernambucq EC, van Meerbeeck JP, Senan S, Kraaij CJ, Chouaki N, Praag J, van Klaveren RJ. Surmont V, et al. Lung Cancer. 2010 Sep;69(3):302-6. doi: 10.1016/j.lungcan.2009.12.001. Epub 2010 Jan 22. Lung Cancer. 2010. PMID: 20096951 Clinical Trial.

8

Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancer.

De Craene S, Surmont V, van Meerbeeck JP. De Craene S, et al. Curr Opin Oncol. 2010 Mar;22(2):102-11. doi: 10.1097/cco.0b013e328335c076. Curr Opin Oncol. 2010. PMID: 20180283

9

Malignant pleural mesothelioma: the standard of care and challenges for future management.

van Meerbeeck JP, Scherpereel A, Surmont VF, Baas P. van Meerbeeck JP, et al. Among authors: surmont vf. Crit Rev Oncol Hematol. 2011 May;78(2):92-111. doi: 10.1016/j.critrevonc.2010.04.004. Epub 2010 May 13. Crit Rev Oncol Hematol. 2011. PMID: 20466560 Review.

10

A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer.

Surmont V, Aerts JG, van Klaveren RJ, Tournoy K, Tan KY, Vernhout RM, Schmitz PI, Legrand C, Hoogsteden HC, van Meerbeeck JP. Surmont V, et al. Oncology. 2010;78(3-4):267-70. doi: 10.1159/000315733. Epub 2010 Jun 7. Oncology. 2010. PMID: 20523087 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page